Helen Xu
谢谢刘先生。我将继续代表CEO介绍公司2014年第三季度的业绩。2014年第三季度财务业绩方面,截至2014年9月30日的三个月期间,公司净收入约为3100万美元,较2013年同期下降约6%。这一下降主要源于溴素和原盐业务板块的减少。溴素产品板块收入下降约6.5%,原盐板块收入下降约32%,但化工产品板块项目收入增长约4.5%。2014年第三季度毛利润为920万美元,占净收入的30%,而2013年同期为1090万美元,占净收入的33%。毛利率百分比的下降主要由于溴素和原盐板块利润率百分比的降低。2014年第三季度和2013年第三季度的研发总成本分别为31,000美元和33,000美元,下降7%。研发成本方面,我们目前为SYCI化工预留了用于测试制造工艺的原材料。截至2014年9月30日的三个月期间,一般及行政费用约为190万美元,较2013年同期下降3%。一般及行政费用的减少主要源于与集体诉讼相关的法律成本和费用,如我们2014年10-K表格所述,且由于该诉讼已于2014年初和解,我们已处理了所有相关的内部部分。截至2014年9月30日的三个月期间,其他营业收入为116,900美元,较2013年同期增长9%,主要来自废水销售。2014年第三季度运营收入为670万美元,较2013年同期下降约39%。这一下降主要源于溴素和原盐销售价格的降低。其他净收入76,700美元代表2014年第三季度的银行利息收入减去应税利息支出,较2013年同期增长116%,主要由于2014年第三季度持有的平均预付款余额较高。2014年第三季度净利润为500万美元,较2013年同期下降约38%。这一显著下降主要归因于溴素和原盐销售价格的降低。2014年第三季度所得税为170万美元,较2013年第三季度下降39%。公司2014年第三季度和2013年第三季度的实际税率均为26%。现在我们将讨论截至2014年9月30日的九个月运营业绩。截至2014年9月30日的九个月期间,净利润为5000万美元,较2013年同期的1530万美元下降约2%。净收入为8800万美元,较2013年同期增长约0.2%。截至2014年9月30日的九个月期间,毛利润为7500万美元,2013年同期也为7500万美元。毛利率百分比的增长主要源于化工产品板块利润率百分比的提高,但被我们的总成本板块所抵消。截至2014年9月30日的九个月期间,运营收入为2000万美元,较2013年同期的运营收入减少100万美元。财务状况方面,截至2014年9月30日,公司拥有现金1.32亿美元,总负债1390万美元,股东权益2071亿美元。截至2014年9月30日,公司营运资本为1.749亿美元。截至2014年9月30日,公司经营活动产生现金流3250万美元,为土地租赁预付款支付了约66万美元现金。同期,我们还使用了约646万美元现金用于第三阶段增强工程项目,该项目涉及截至2014年9月30日的九个月期间10号和11号工厂的防护架至传输通道和管道。对于进一步的投资者问询,投资者可继续通过我们的网站联系我们的投资者关系经理和CEO助理,并披露我们的电子邮件地址。至此,我们愿意开放电话会议,回答有关2014年第三季度财务和运营业绩的任何问题。接线员。
Helen Xu
Thank you Mr. Liu. I’m going to continue with presenting the company’s results for the third quarter of 2014 on behalf of the CEO. For the third quarter 2014 financial results the company’s net revenue was around $31 million for the three months period ended September 30, 2014, a decrease of approximately 6% as compared with the same period of 2013. This decrease was mainly due to the decrease in our Bromine and Crude Salt segment. The revenue from Bromine product segment decreased approximately 6.5%, revenue from the crude salt segment decreased approximately 32%, but revenue from the chemical product segment projects increased approximately 4.5%. Gross profit was $9.2 million or 30% of net revenue for the third quarter of 2014 as compared to $10.9 million or 33% of net revenue for the same period in 2013. The decrease in gross profit percentage was mainly due to the decrease in the margin percent of bromine and crude salt segments. The total research and development costs incurred for the third quarter of 2014 and 2013 were $31,000 and $33,000 respectively, a decrease of 7%. Research and development costs; we currently reserved (ph) raw materials used by SYCI chemical for testing the manufacturing routine. General and administrative expenses were around $1.9 million for the three months period ending September 30, 2014, a decrease of 3% as compared to the same period in 2013. This decrease in general and administrative expenses were primarily due to legal costs and expenses incurred in connection with the Class Action, also as described in our 2014 Form 10-K and deal with all our particular internal portion since the lawsuit was settled in early 2014. Other operating income was $116,900 for the three-month period ended September 30, 2014, an increase of 9% as compared to the same period in 2013 of sales of wastewater. Income from operations was $6.7 million for the third quarter of 2014, a decrease of around 39% over the same period in 2013. The decrease resulted primarily from the decrease in bromine and crude salt selling prices. Other income net of $76,700 represented the bank interest income and net of taxable interest expense for the third quarter of 2014, an increase of 116% as compared to the same period of 2013, mainly due to higher average advance balance held during the third quarter of 2014. Net income was $5.0 million for the third quarter of 2014, a decrease of approximately 38% as compared to the same period in 2013. This significant decrease was primarily attributable to the decrease in the selling price of bromine and crude salt. Income taxes were $1.7 million for the third quarter of 2014, a decrease of 39% of the third quarter of 2013. The company’s effective tax rate was 26% for the third quarter of 2014 and 2013 respectively. So now we are going to discuss about the nine months ended September 30, 2014 operating results. The net income was $50 million for the nine months period ended September 30, 2014, a decrease of around 2% compared to the same period in 2013, which was $15.3 million. The net revenue was $88 million, which you can see an increase of approximately 0.2% over the same period in 2013. Gross profit was $75 million for the nine months period ended September 30, 2014 and $75 million for the same period in 2013. The increase in gross profit percentage was mainly due to the increase in the margin percentage of our chemical product segment, which was offset by our gross cost segment. Income from operations was $20 million for the nine-month period ended September 30, 2014, and a decrease of $1 million over our income from operations for the same period in 2013. For the financial condition, as of September 30, 2014 the company had cash of $132 million, total liability of $13.9 million and stockholder equity of $207,100 million. As of September 30, 2014 the company had working of $174.9 million. As of September 30, 2014, the company generated $32.5 million in cash flow from operation, yielded approximately $0.66 million cash for the prepayment of land leases. In the same period, we also used around $6.46 million cash for our third phase enhancement work project, which related to the protective shelf to transmission channel and ducts in Factory No. 10 and 11 for the nine month period ended September 30, 2014. So for further inventing inquiries, investors may continue to reach our IR manager and CEO assistant at our website and disclosed our email address. With that, we would like to open up the call to any questions pertaining to the third quarter 2014 financial and operating performance. Operator.